Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bernd Eilbacher"'
Autor:
Wojciech Danysz, Aigars Jirgensons, Vladimir A. Kashkin, Bernd Eilbacher, Sergio Greco, A. Malyshkin, Jens Nagel, Anton Bespalov, Elena V. Shekunova, Irina V Belozertseva
Publikováno v:
Neuropharmacology. 51:1163-1171
N-acetylated-alpha-linked-acidic peptidase (NAAG peptidase) converts N-acetyl-aspartyl-glutamate (NAAG, mGluR3 agonist) into N-acetyl-aspartate and glutamate. The NAAG peptidase inhibitor 2-PMPA (2-(phosphonomethyl)pentanedioic acid) had neuroprotect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6c909fccd7c8fe8b56acb5046604554
https://doi.org/10.1016/j.neuropharm.2006.07.018
https://doi.org/10.1016/j.neuropharm.2006.07.018
Autor:
Bernd Eilbacher, Günter Quack, Mayke B. Hesselink, Wojciech Danysz, Tadeusz Frankiewicz, Peter Spielmanns, Annette Bartmann, Chris G. Parsons
Publikováno v:
Neuropharmacology. 38(1)
The present study characterized the in vitro NMDA receptor antagonistic properties of novel amino-alkyl-cyclohexane derivatives and compared these effects with their ability to block excitotoxicity in vitro and MES-induced convulsions in vivo. The 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb70365de9a3f5a974374593b701734d
https://pubmed.ncbi.nlm.nih.gov/10193901
https://pubmed.ncbi.nlm.nih.gov/10193901
Publikováno v:
European journal of pharmacology. 262(1-2)
Memantine (1-amino-3,5-dimethyl-adamantane) has therapeutic potential in Parkinson's disease and dementia. However, its effect on dopaminergic activity in the central nervous system is still unclear. Therefore, we studied the effect of memantine on d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae8e24cb337121473c3147e4f8f2f63
https://pubmed.ncbi.nlm.nih.gov/7813574
https://pubmed.ncbi.nlm.nih.gov/7813574